Comments

Nektar Therapeutics Stock Price, Quotes and Forecasts

NKTRNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
Q1 2025 Earnings were released on Thu May 8th, after the market close
The most recent conference call was at 17:00 PM, 5 days ago Click to view past webcast

Nektar Therapeutics (NKTR) Forecast

NewsEarningsNektar Therapeutics (NKTR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Nektar Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NKTR | Benzinga

Explore Nektar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NKTR.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Jan
1
Feb
2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$0.71
Close-
Volume / Avg.1.58M / 2.38M
Day Range$0.66 - $0.71
52 Wk Range0.43 - 1.93
Market Cap$131.91M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
52
Short Interest
4.94%
Days to Cover4.9
About Nektar Therapeutics
Sector
Health Care
Industry
Pharmaceuticals
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company foc...
Show More
Got Questions? Ask
How is NKTR's revenue growing?
What is NKTR's gross margin?
What is NKTR's P/E ratio?
What is NKTR's ROA?
What’s driving NKTR's recent performance?
Powered By

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NKTR
AVIR

FAQ

Q

How do I buy Nektar Therapeutics (NKTR) stock?

A

You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Nektar Therapeutics (NKTR) competitors?

A

Other companies in Nektar Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA) and Terns Pharma (NASDAQ:TERN).

Q

What is the forecast, or price target, for Nektar Therapeutics (NKTR) stock?

A

Nektar Therapeutics has a consensus price target of $4.50.

Q

What is the current price for Nektar Therapeutics (NKTR)?

A

The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $0.7083 last updated May 13, 2025 at 1:31 PM EDT.

Q

Does Nektar Therapeutics (NKTR) pay a dividend?

A

There are no upcoming dividends for Nektar Therapeutics.

Q

When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?

A

Nektar Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Q

Is Nektar Therapeutics (NKTR) going to split?

A

There is no upcoming split for Nektar Therapeutics.

Q

What sector and industry does Nektar Therapeutics (NKTR) operate in?

A

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved